speb/financial-data huggingface dataset:
DuPont ROE decomposition for CBR.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.816101494921009
ROE archetype: Standard Business
DuPont ROE decomposition for CBR.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.732443919513078
ROE archetype: Standard Business
DuPont ROE decomposition for CCAVENUE.NS (annual period ending 2022-03-31)
ROE: 2.928066423653849%
Net margin: 6.68660592149498%
Asset turnover: 0.3357071064269855
Equity multiplier (leverage): 1.304411626846836
EBIT margin: 6.363559079702921%
Interest burden factor: 1.1945591450085011
Tax burden factor: 0.8796258641724278
ROE archetype: Low Return
DuPont ROE decomposition for CCAVENUE.NS (annual period ending 2023-03-31)
ROE: 4.385992530035514%
Net margin: 7.1138574935319525%
Asset turnover: 0.4741635139782973
Equity multiplier (leverage): 1.3002731476059382
EBIT margin: 6.206165193679583%
Interest burden factor: 1.4961982493882713
Tax burden factor: 0.7661127453132546
ROE archetype: Low Return
DuPont ROE decomposition for CCAVENUE.NS (annual period ending 2024-03-31)
ROE: 4.788286750082505%
Net margin: 5.018252345823228%
Asset turnover: 0.6766832977176372
Equity multiplier (leverage): 1.4100749491848996
EBIT margin: 5.977944817603515%
Interest burden factor: 1.1018362166926858
Tax burden factor: 0.7618746987951807
ROE archetype: Low Return
DuPont ROE decomposition for CCAVENUE.NS (annual period ending 2025-03-31)
ROE: 6.450733201880449%
Net margin: 5.911716233613353%
Asset turnover: 0.7502219743405921
Equity multiplier (leverage): 1.454473188630853
EBIT margin: 5.83682731466871%
Interest burden factor: 1.3225197391005836
Tax burden factor: 0.7658338741077223
ROE archetype: Standard Business
DuPont ROE decomposition for CCAVENUE.NS (annual period ending 2026-03-31)
ROE: 6.398692006364126%
Net margin: 3.6335072728056828%
Asset turnover: 1.2274240371597411
Equity multiplier (leverage): 1.4347312195496582
EBIT margin: 3.4309406901310395%
Interest burden factor: 1.2253187286766025
Tax burden factor: 0.8642984847152614
ROE archetype: Standard Business
DuPont ROE decomposition for CCBG (annual period ending 2022-12-31)
ROE: 8.436564168084882%
Net margin: 17.25211572321848%
Asset turnover: 0.04285449069452869
Equity multiplier (leverage): 11.411084289891374
Tax burden factor: 0.8134388314059647
ROE archetype: Standard Business
DuPont ROE decomposition for CCBG (annual period ending 2023-12-31)
ROE: 12.382385347186844%
Net margin: 23.369735347518493%
Asset turnover: 0.05068486009270488
Equity multiplier (leverage): 10.453753835582356
Tax burden factor: 0.8183085138034168
ROE archetype: Standard Business
DuPont ROE decomposition for CCBG (annual period ending 2024-12-31)
ROE: 11.218541600192506%
Net margin: 23.361721478302716%
Asset turnover: 0.052495599640717
Equity multiplier (leverage): 9.14763147043141
Tax burden factor: 0.8070247681795998
ROE archetype: Standard Business
DuPont ROE decomposition for CCBG (annual period ending 2025-12-31)
ROE: 11.74563619572435%
Net margin: 25.184618468802032%
Asset turnover: 0.056120193366845386
Equity multiplier (leverage): 8.31040157684646
Tax burden factor: 0.7532949080362715
ROE archetype: Standard Business
DuPont ROE decomposition for CCE.AX (annual period ending 2022-06-30)
ROE: -9.28286953470622%
Net margin: -597.8418204747497%
Asset turnover: 0.014960242469517632
Equity multiplier (leverage): 1.0379043271393036
EBIT margin: -720.8816604439364%
ROE archetype: Low Return
DuPont ROE decomposition for CCE.AX (annual period ending 2023-06-30)
ROE: -2.944676457862848%
Net margin: -164.27813841250648%
Asset turnover: 0.017093602860038453
Equity multiplier (leverage): 1.04863464463505
EBIT margin: -605.7990238105785%
ROE archetype: Low Return
DuPont ROE decomposition for CCE.AX (annual period ending 2024-06-30)
ROE: -11.001010956787773%
Net margin: -668.805001715088%
Asset turnover: 0.01550937790494986
Equity multiplier (leverage): 1.0605684577150314
EBIT margin: -694.0358179527905%
ROE archetype: Low Return
DuPont ROE decomposition for CCE.AX (annual period ending 2025-06-30)
ROE: -11.422343190372029%
Net margin: -733.4610524856395%
Asset turnover: 0.01259937915986812
Equity multiplier (leverage): 1.2360299714609881
EBIT margin: -568.2927751502224%
ROE archetype: Low Return
DuPont ROE decomposition for CCIX (annual period ending 2023-12-31)
Equity multiplier (leverage): 10.8164515061238
ROE archetype: Standard Business
DuPont ROE decomposition for CCIX (annual period ending 2024-12-31)
ROE: 6.084489833199127%
Asset turnover: 0
Equity multiplier (leverage): 1.0352839410918269
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CCIX (annual period ending 2025-12-31)
ROE: 2.9177347404486405%
Asset turnover: 0
Equity multiplier (leverage): 1.03473470997964
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CCK (annual period ending 2022-12-31)
ROE: 37.38522081329253%
Net margin: 6.6058873522367305%
Asset turnover: 0.9050416054821341
Equity multiplier (leverage): 6.25317009182335
EBIT margin: 9.920420304411651%
Interest burden factor: 0.822429906542056
Tax burden factor: 0.8096590909090909
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCK (annual period ending 2023-12-31)
ROE: 22.791690933799263%
Net margin: 4.88759367194005%
Asset turnover: 0.8188171126640532
Equity multiplier (leverage): 5.695010677538342
EBIT margin: 11.51540383014155%
Interest burden factor: 0.5748373101952278
Tax burden factor: 0.7383647798742138
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCK (annual period ending 2024-12-31)
ROE: 18.384766907419568%
Net margin: 4.745360562664181%
Asset turnover: 0.8171871754033654
Equity multiplier (leverage): 4.740971766250821
EBIT margin: 12.659944072536225%
Interest burden factor: 0.49732262382864795
Tax burden factor: 0.7537012113055181
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCK (annual period ending 2025-12-31)
ROE: 26.326774001192604%
Net margin: 7.141124140719773%
Asset turnover: 0.8794452347083926
Equity multiplier (leverage): 4.19200954084675
EBIT margin: 13.230893651435505%
Interest burden factor: 0.7090464547677262
Tax burden factor: 0.7612068965517241
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CCL.NS (annual period ending 2023-03-31)
ROE: 18.96512008826587%
Net margin: 13.709999343380893%
Asset turnover: 0.797562355286024
Equity multiplier (leverage): 1.734416976753738
EBIT margin: 15.584999343380893%
Interest burden factor: 0.9448684785268852
Tax burden factor: 0.9310205880212169
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CCL.NS (annual period ending 2024-03-31)
ROE: 15.656111998850712%
Net margin: 9.423733828621524%
Asset turnover: 0.8596862620028412
Equity multiplier (leverage): 1.9325063148845005
EBIT margin: 12.453140911741068%
Interest burden factor: 0.8358957009898959
Tax burden factor: 0.9052989508673147
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CCL.NS (annual period ending 2025-03-31)
ROE: 16.84690626647295%
Net margin: 9.99232101722035%
Asset turnover: 0.7894582529498677
Equity multiplier (leverage): 2.135623113128243
EBIT margin: 14.702761481212637%
Interest burden factor: 0.771417840663468
Tax burden factor: 0.8810038117456954
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CCL.NS (annual period ending 2026-03-31)
ROE: 17.192961615920026%
Net margin: 8.706892269783815%
Asset turnover: 0.9900265149132941
Equity multiplier (leverage): 1.9945305676631684
EBIT margin: 13.034963595376595%
Interest burden factor: 0.7929169026035383
Tax burden factor: 0.8424141878566056
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CCMI.V (annual period ending 2022-05-31)
ROE: -81.22457707263084%
Net margin: -3477413.0081300805%
Asset turnover: 9.04922513618716e-06
Equity multiplier (leverage): 2.581188913761632
EBIT margin: -2474002.43902439%
ROE archetype: Low Return
DuPont ROE decomposition for CCMI.V (annual period ending 2023-05-31)
ROE: 20.723664451250503%
Asset turnover: 0
Equity multiplier (leverage): 2.0344510662170356
Tax burden factor: 1.1169446359574586
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CCMI.V (annual period ending 2024-05-31)
ROE: 1.4680816181152263%
Net margin: 106444.71544715448%
Asset turnover: 8.790796684355645e-06
Equity multiplier (leverage): 1.5689093812023076
EBIT margin: -2653515.4471544717%
Tax burden factor: 2.4098472298914047
ROE archetype: Low Return
DuPont ROE decomposition for CCO.TO (annual period ending 2022-12-31)
ROE: 1.5315456561912866%
Net margin: 4.784895955734546%
Asset turnover: 0.2163845466930575
Equity multiplier (leverage): 1.4792146763272855
EBIT margin: 0.8332427731647113%
Interest burden factor: 5.447799550273048
Tax burden factor: 1.05409517070582
ROE archetype: Low Return
DuPont ROE decomposition for CCO.TO (annual period ending 2023-12-31)
ROE: 6.137519145952026%
Net margin: 13.944387380891103%
Asset turnover: 0.28261517692434807
Equity multiplier (leverage): 1.557392002765926
EBIT margin: 11.015288137453348%
Interest burden factor: 1.7090149412907956
Tax burden factor: 0.7407262194834067
ROE archetype: Standard Business
DuPont ROE decomposition for CCO.TO (annual period ending 2024-12-31)
ROE: 2.650722795541098%
Net margin: 5.480404825350823%
Asset turnover: 0.30342898595746653
Equity multiplier (leverage): 1.5940230869143555
EBIT margin: 16.30080248181309%
Interest burden factor: 0.5022263262096112
Tax burden factor: 0.6694284734882127
ROE archetype: Low Return
DuPont ROE decomposition for CCO.TO (annual period ending 2025-12-31)
ROE: 9.06994371338973%
Net margin: 16.93246251435625%
Asset turnover: 0.3518417159069098
Equity multiplier (leverage): 1.5224293190670142
EBIT margin: 17.842359402090736%
Interest burden factor: 1.2511062213988047
Tax burden factor: 0.7585315614703427
ROE archetype: Standard Business
DuPont ROE decomposition for CCR.L (quarterly period ending 2025-02-28)
Equity multiplier (leverage): 2.4039593365436063
ROE archetype: Standard Business
DuPont ROE decomposition for CCR.L (quarterly period ending 2026-02-28)
Equity multiplier (leverage): 2.4605120607435533
ROE archetype: Standard Business
DuPont ROE decomposition for CCV.AX (annual period ending 2022-06-30)
ROE: 3.5442933610695353%
Net margin: 5.266977366652688%
Asset turnover: 0.4437773428024124
Equity multiplier (leverage): 1.516362667749055
EBIT margin: 1.792572416815498%
Interest burden factor: 4.044426919032598
Tax burden factor: 0.7264868378290543
ROE archetype: Low Return
DuPont ROE decomposition for CCV.AX (annual period ending 2023-06-30)
ROE: -36.32675243981475%
Net margin: -37.07979665363947%
Asset turnover: 0.5570991257619055
Equity multiplier (leverage): 1.7585582306046195
EBIT margin: 1.1556546165119685%
Interest burden factor: -30.05911492734478
ROE archetype: Low Return
DuPont ROE decomposition for CCV.AX (annual period ending 2024-06-30)
ROE: 8.354052192986124%
Net margin: 4.612851392844075%
Asset turnover: 0.8218611937612923
Equity multiplier (leverage): 2.2035821511994382
EBIT margin: 12.431922193762562%
Interest burden factor: 0.5729642110651367
Tax burden factor: 0.6475952948183443
ROE archetype: Standard Business
DuPont ROE decomposition for CCV.AX (annual period ending 2025-06-30)
ROE: 11.039509386401134%
Net margin: 6.423691280802653%
Asset turnover: 0.7831453612687836
Equity multiplier (leverage): 2.1944350555984014
EBIT margin: 12.899070148188574%
Interest burden factor: 0.6987775359518337
Tax burden factor: 0.7126681026954649
ROE archetype: Standard Business
DuPont ROE decomposition for CD.V (quarterly period ending 2025-01-31)
ROE: -104.31161392207417%
Asset turnover: 0
Equity multiplier (leverage): 3.645049116264129
ROE archetype: Low Return
DuPont ROE decomposition for CD.V (quarterly period ending 2025-04-30)
ROE: -137.62268870724355%
Asset turnover: 0
Equity multiplier (leverage): 5.1583994215037015
ROE archetype: Low Return
DuPont ROE decomposition for CD.V (quarterly period ending 2025-07-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for CD.V (quarterly period ending 2025-10-31)
ROE: -298.4197016814174%
Asset turnover: 0
Equity multiplier (leverage): 2.961383143516552
ROE archetype: Low Return
DuPont ROE decomposition for CD.V (quarterly period ending 2026-01-31)
ROE: -17.368967845111843%
Asset turnover: 0
Equity multiplier (leverage): 1.983127178363748
ROE archetype: Low Return
DuPont ROE decomposition for CD.V (quarterly period ending 2026-04-30)
ROE: -31.40606213990635%
Asset turnover: 0
Equity multiplier (leverage): 1.9421304377953759
ROE archetype: Low Return
DuPont ROE decomposition for CDIO (quarterly period ending 2025-03-31)
ROE: -14.37151054045312%
Net margin: -173942.97872340426%
Asset turnover: 7.653403101973128e-05
Equity multiplier (leverage): 1.079545438564417
EBIT margin: -173463.82978723405%
ROE archetype: Low Return
DuPont ROE decomposition for CDIO (quarterly period ending 2025-06-30)
ROE: -15.953117596165525%
Net margin: -22517.712374581937%
Asset turnover: 0.0006592098785356193
Equity multiplier (leverage): 1.0747255959308533
EBIT margin: -22457.511705685618%
ROE archetype: Low Return
DuPont ROE decomposition for CDIO (quarterly period ending 2025-09-30)
ROE: -19.182256701202206%
Net margin: -60053.8003502627%
Asset turnover: 0.0002976213900440902
Equity multiplier (leverage): 1.0732355799056514
EBIT margin: -59950.85814360771%
ROE archetype: Low Return
DuPont ROE decomposition for CDIO (quarterly period ending 2025-12-31)
ROE: -19.37686302576707%
Net margin: -41219.915611814344%
Asset turnover: 0.00042946927564117317
Equity multiplier (leverage): 1.0945718408521035
EBIT margin: -41159.54992967651%
ROE archetype: Low Return
DuPont ROE decomposition for CDIO (quarterly period ending 2026-03-31)
ROE: -22.525487421766908%
Net margin: -66722.31343283583%
Asset turnover: 0.0003093654740973945
Equity multiplier (leverage): 1.0912675910496308
EBIT margin: -66598.39552238806%
ROE archetype: Low Return
DuPont ROE decomposition for CDPR.V (quarterly period ending 2024-12-31)
ROE: -18.186424809789596%
Asset turnover: 0
Equity multiplier (leverage): 2.61003535796504
ROE archetype: Low Return
DuPont ROE decomposition for CDPR.V (quarterly period ending 2025-03-31)
ROE: -50.76953671282926%
Asset turnover: 0
Equity multiplier (leverage): 2.5178902129447955
Tax burden factor: -1.4056696009612062
ROE archetype: Low Return
DuPont ROE decomposition for CDPR.V (quarterly period ending 2025-06-30)
ROE: -21.463681211170933%
Asset turnover: 0
Equity multiplier (leverage): 2.3094213493740408
ROE archetype: Low Return
DuPont ROE decomposition for CDPR.V (quarterly period ending 2025-09-30)
ROE: -22.80357926771879%
Asset turnover: 0
Equity multiplier (leverage): 2.2200190830154805
ROE archetype: Low Return
DuPont ROE decomposition for CDPR.V (quarterly period ending 2025-12-31)
ROE: -2.590828900604952%
Asset turnover: 0
Equity multiplier (leverage): 1.4444784145394893
ROE archetype: Low Return
DuPont ROE decomposition for CDPR.V (quarterly period ending 2026-03-31)
ROE: -1.0804875416834299%
Asset turnover: 0
Equity multiplier (leverage): 1.1367723883451304
ROE archetype: Low Return
DuPont ROE decomposition for CDR.AX (annual period ending 2021-06-30)
ROE: -88.8006871781266%
Equity multiplier (leverage): 1.0383396357757355
ROE archetype: Low Return
DuPont ROE decomposition for CDR.AX (annual period ending 2022-06-30)
ROE: -69.29630635178968%
Equity multiplier (leverage): 1.051164127777576
ROE archetype: Low Return
DuPont ROE decomposition for CDR.AX (annual period ending 2023-06-30)
ROE: -93.18635247005889%
Equity multiplier (leverage): 1.1013076205017989
ROE archetype: Low Return
DuPont ROE decomposition for CDR.AX (annual period ending 2024-06-30)
ROE: -171.70873130757067%
Net margin: -1054.2303333333332%
Asset turnover: 0.13827058713289994
Equity multiplier (leverage): 1.1779505639163317
EBIT margin: -1172.5553333333332%
ROE archetype: Low Return
DuPont ROE decomposition for CEIA.L (annual period ending 2022-12-31)
ROE: 6.703977337135562%
Net margin: 0.7958592602702801%
Asset turnover: 2.366665395546224
Equity multiplier (leverage): 3.5592574507763897
EBIT margin: 0.8589827243833488%
Interest burden factor: 1.1632642900306833
Tax burden factor: 0.7964773832469394
ROE archetype: Standard Business
DuPont ROE decomposition for CEIA.L (annual period ending 2023-12-31)
ROE: 7.188308526429308%
Net margin: 0.9644592014406029%
Asset turnover: 2.180363883321845
Equity multiplier (leverage): 3.4183290723693514
EBIT margin: 1.2725808237074143%
Interest burden factor: 0.9869447399593168
Tax burden factor: 0.767901736060738
ROE archetype: Standard Business
DuPont ROE decomposition for CEIA.L (annual period ending 2024-12-31)
ROE: 8.03979717962085%
Net margin: 1.2847703541383675%
Asset turnover: 2.009740328405636
Equity multiplier (leverage): 3.1137205918363557
EBIT margin: 1.6305398179045214%
Interest burden factor: 1.0341024595139832
Tax burden factor: 0.761957111810202
ROE archetype: Standard Business
DuPont ROE decomposition for CEIA.L (annual period ending 2025-12-31)
ROE: 5.40374379846713%
Net margin: 1.0429501126865104%
Asset turnover: 1.7460586855415623
Equity multiplier (leverage): 2.9673746237306338
EBIT margin: 1.4041276623320922%
Interest burden factor: 0.9823143059949513
Tax burden factor: 0.756147413698467
ROE archetype: Standard Business
DuPont ROE decomposition for CEN.AX (annual period ending 2022-06-30)
ROE: 6.408450704225352%
Net margin: 7.666385846672284%
Asset turnover: 0.45954316686024
Equity multiplier (leverage): 1.8190140845070422
EBIT margin: 11.036225779275483%
Interest burden factor: 0.9656488549618321
Tax burden factor: 0.7193675889328064
ROE archetype: Standard Business
DuPont ROE decomposition for CEN.AX (annual period ending 2023-06-30)
ROE: 4.444787423210195%
Net margin: 6.044740599714421%
Asset turnover: 0.3784785043508228
Equity multiplier (leverage): 1.9428179521848956
EBIT margin: 12.56544502617801%
Interest burden factor: 0.6704545454545455
Tax burden factor: 0.7175141242937852
ROE archetype: Low Return
DuPont ROE decomposition for CEN.AX (annual period ending 2024-06-30)
ROE: 8.694033908413875%
Net margin: 8.271735304470257%
Asset turnover: 0.4742588141025641
Equity multiplier (leverage): 2.2162017329771264
EBIT margin: 14.18514607532559%
Interest burden factor: 0.8387096774193549
Tax burden factor: 0.6952662721893491
ROE archetype: Standard Business
DuPont ROE decomposition for CEN.AX (annual period ending 2025-06-30)
ROE: 12.270690288491425%
Net margin: 9.7010550996483%
Asset turnover: 0.5225573529219499
Equity multiplier (leverage): 2.420561159616852
EBIT margin: 20.779601406799532%
Interest burden factor: 0.6530324400564175
Tax burden factor: 0.714902807775378
ROE archetype: Standard Business
DuPont ROE decomposition for CENX (quarterly period ending 2025-03-31)
ROE: 4.2999855219342695%
Net margin: 4.685281590156176%
Asset turnover: 0.32432847275518034
Equity multiplier (leverage): 2.8297379470102793
EBIT margin: 6.751853604669507%
Interest burden factor: 0.5607476635514018
Tax burden factor: 1.2375
ROE archetype: Low Return
DuPont ROE decomposition for CENX (quarterly period ending 2025-06-30)
ROE: -0.6690909090909091%
Net margin: -0.7323674574112402%
Asset turnover: 0.3218137568848469
Equity multiplier (leverage): 2.838909090909091
EBIT margin: 3.2956535583505806%
Interest burden factor: -0.5024154589371981
ROE archetype: Low Return
DuPont ROE decomposition for CENX (quarterly period ending 2025-09-30)
ROE: 2.156763407396685%
Net margin: 2.3568490983865864%
Asset turnover: 0.3096590909090909
Equity multiplier (leverage): 2.9552001157993777
EBIT margin: 9.221765264156913%
Interest burden factor: 0.16295025728987994
Tax burden factor: 1.568421052631579
ROE archetype: Low Return
DuPont ROE decomposition for CENX (quarterly period ending 2025-12-31)
ROE: 0.24580593621335955%
Net margin: 0.31560675398453525%
Asset turnover: 0.2878165095946406
Equity multiplier (leverage): 2.706016100288822
EBIT margin: 5.207511440744832%
Interest burden factor: -0.7181818181818181
ROE archetype: Low Return
DuPont ROE decomposition for CENX (quarterly period ending 2026-03-31)
ROE: 30.48229768786127%
Net margin: 51.98706099815157%
Asset turnover: 0.26367734860484954
Equity multiplier (leverage): 2.223717485549133
EBIT margin: 13.262476894639558%
Interest burden factor: 3.818815331010453
Tax burden factor: 1.0264598540145986
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CEPF (annual period ending 2023-12-31)
ROE: -67.23470178156468%
Asset turnover: 0
Equity multiplier (leverage): 1
ROE archetype: Low Return
DuPont ROE decomposition for CEPF (annual period ending 2024-12-31)
ROE: -429.3723339427179%
Asset turnover: 0
Equity multiplier (leverage): 1.6666666666666667
ROE archetype: Low Return
DuPont ROE decomposition for CEPF (annual period ending 2025-12-31)
ROE: 2.684471436934574%
Asset turnover: 0
Equity multiplier (leverage): 1.0002136143408573
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CERS (quarterly period ending 2025-03-31)
ROE: -13.721062551118383%
Net margin: -17.847313767663454%
Asset turnover: 0.2091103416257206
Equity multiplier (leverage): 3.6765406635610396
EBIT margin: -13.536390758343162%
ROE archetype: Low Return
DuPont ROE decomposition for CERS (quarterly period ending 2025-06-30)
ROE: -10.153720243390385%
Net margin: -10.881876251310898%
Asset turnover: 0.24982910441184528
Equity multiplier (leverage): 3.734894851083514
EBIT margin: -6.526837639431786%
ROE archetype: Low Return
DuPont ROE decomposition for CERS (quarterly period ending 2025-09-30)
ROE: -0.03210164394208188%
Net margin: -0.03605449922198186%
Asset turnover: 0.24610513337816634
Equity multiplier (leverage): 3.6178214810684777
EBIT margin: 2.3454400546510303%
Interest burden factor: 0.052588996763754045
Tax burden factor: -0.2923076923076923
ROE archetype: Low Return
DuPont ROE decomposition for CERS (quarterly period ending 2025-12-31)
ROE: -3.434799361479606%
Net margin: -3.781752696922997%
Asset turnover: 0.26428002672499795
Equity multiplier (leverage): 3.43671806808263
EBIT margin: -1.109937490259909%
ROE archetype: Low Return
DuPont ROE decomposition for CERS (quarterly period ending 2026-03-31)
ROE: -2.4615199885929564%
Net margin: -3.056223327929036%
Asset turnover: 0.24129937697715884
Equity multiplier (leverage): 3.337813599897937
EBIT margin: -0.6596969866383408%
ROE archetype: Low Return
DuPont ROE decomposition for CERT.V (annual period ending 2022-12-31)
ROE: -44.24142579002543%
Net margin: -6.538291279327135%
Asset turnover: 0.5555623870245809
Equity multiplier (leverage): 12.179571663920914
EBIT margin: 11.971004869411244%
Interest burden factor: -0.07562170657298696
ROE archetype: Low Return
DuPont ROE decomposition for CERT.V (annual period ending 2023-12-31)
ROE: -20.606574417651473%
Net margin: -3.8850760731661023%
Asset turnover: 0.48998706731546526
Equity multiplier (leverage): 10.824844273293552
EBIT margin: 0.40259338068550765%
Interest burden factor: 18.086848635235732
Tax burden factor: -0.5335436959802442
ROE archetype: Low Return
DuPont ROE decomposition for CERT.V (annual period ending 2024-12-31)
ROE: 64.83361270176216%
Net margin: 21.863836307448633%
Asset turnover: 0.45317295970612614
Equity multiplier (leverage): 6.54349638806402
EBIT margin: -1.2171921941309645%
Tax burden factor: 8.083704646721834
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CERT.V (annual period ending 2025-12-31)
ROE: -40.3708637501998%
Net margin: -13.868171465479145%
Asset turnover: 0.5084520126596921
Equity multiplier (leverage): 5.725308170808249
EBIT margin: 12.494136043784208%
Interest burden factor: 0.16009141862110246
Tax burden factor: -6.933378653976887
ROE archetype: Low Return
DuPont ROE decomposition for CETY (annual period ending 2021-12-31)
Net margin: 22.8808117874041%
Asset turnover: 0.2021740678335531
EBIT margin: -120.94077461534143%
Tax burden factor: 1.0684364362351522
ROE archetype: Standard Business
DuPont ROE decomposition for CETY (annual period ending 2022-12-31)
ROE: 188.38347690498708%
Net margin: 5.534482421977672%
Asset turnover: 0.36616273916322595
Equity multiplier (leverage): 92.95904373610081
EBIT margin: -37.16380821354065%
Tax burden factor: 0.8896473883074397
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CETY (annual period ending 2023-12-31)
ROE: -142.80316710367381%
Net margin: -82.6395416445319%
Asset turnover: 0.7030263184151186
Equity multiplier (leverage): 2.4579800640060387
EBIT margin: -43.71156543235845%
ROE archetype: Low Return
DuPont ROE decomposition for CETY (annual period ending 2024-12-31)
ROE: -117.17988762535984%
Net margin: -187.6674616925514%
Asset turnover: 0.24725167876908657
Equity multiplier (leverage): 2.525369018597299
EBIT margin: -137.35667572223556%
ROE archetype: Low Return
DuPont ROE decomposition for CETY (annual period ending 2025-12-31)
ROE: -167.2178465378692%
Net margin: -314.9895032720739%
Asset turnover: 0.20492685988014825
Equity multiplier (leverage): 2.5905242332087632
EBIT margin: -118.39939008875726%
ROE archetype: Low Return
DuPont ROE decomposition for CF.TO (quarterly period ending 2024-12-31)
ROE: -0.8586139633733029%
Net margin: -2.5725333345158012%
Asset turnover: 0.08264130276849482
Equity multiplier (leverage): 4.038683137925829
EBIT margin: 10.025408284076144%
Interest burden factor: -0.11482153124861781
ROE archetype: Low Return
DuPont ROE decomposition for CF.TO (quarterly period ending 2025-03-31)
ROE: 0.8004923613640706%
Net margin: 2.3561066459682545%
Asset turnover: 0.07574584846888861
Equity multiplier (leverage): 4.485423076087288
EBIT margin: 9.698695002677642%
Interest burden factor: 0.4087139248429571
Tax burden factor: 0.5943772903790407
ROE archetype: Low Return
DuPont ROE decomposition for CF.TO (quarterly period ending 2025-06-30)
ROE: -1.2933456061571844%
Net margin: -3.756296730717342%
Asset turnover: 0.06740080855424603
Equity multiplier (leverage): 5.108455249417052
EBIT margin: 10.179575289833583%
Interest burden factor: -0.2609638554216867
ROE archetype: Low Return
DuPont ROE decomposition for CF.TO (quarterly period ending 2025-09-30)
ROE: -15.407077692780158%
Net margin: -34.86620715913481%
Asset turnover: 0.07480506139788116
Equity multiplier (leverage): 5.907239549158147
EBIT margin: 0.672463703197702%
Interest burden factor: -44.002220371912294
ROE archetype: Low Return
DuPont ROE decomposition for CF.TO (quarterly period ending 2025-12-31)
ROE: 3.4999510155876052%
Net margin: 6.055080965915771%
Asset turnover: 0.09201525055945509
Equity multiplier (leverage): 6.281772418534101
EBIT margin: 17.328226682615806%
Interest burden factor: 0.5809915859947525
Tax burden factor: 0.6014451002071102
ROE archetype: Low Return
DuPont ROE decomposition for CF.TO (quarterly period ending 2026-03-31)
ROE: 7.343553896877491%
Net margin: 13.987175594334397%
Asset turnover: 0.08499861543203543
Equity multiplier (leverage): 6.176812356099517
EBIT margin: 18.453147402724984%
Interest burden factor: 0.8595978705618373
Tax burden factor: 0.8817881235348913
ROE archetype: Standard Business
DuPont ROE decomposition for CFR.SW (annual period ending 2023-03-31)
ROE: 1.6457226983542776%
Net margin: 1.5686864130707163%
Asset turnover: 0.48800352190182705
Equity multiplier (leverage): 2.1497975708502026
EBIT margin: 25.20924171803739%
Interest burden factor: 0.945924453280318
Tax burden factor: 0.06578394283312317
ROE archetype: Low Return
DuPont ROE decomposition for CFR.SW (annual period ending 2024-03-31)
ROE: 11.976169349727467%
Net margin: 11.457120682964685%
Asset turnover: 0.4960617023107826
Equity multiplier (leverage): 2.1072047739305946
EBIT margin: 23.248932867675588%
Interest burden factor: 0.9712080116837054
Tax burden factor: 0.5074113856068743
ROE archetype: Standard Business
DuPont ROE decomposition for CFR.SW (annual period ending 2025-03-31)
ROE: 12.994053773203666%
Net margin: 12.85574092247301%
Asset turnover: 0.5172680524511756
Equity multiplier (leverage): 1.9540329902750588
EBIT margin: 20.944903967475113%
Interest burden factor: 1.0015618027666222
Tax burden factor: 0.6128313655602583
ROE archetype: Standard Business
DuPont ROE decomposition for CFR.SW (annual period ending 2026-03-31)
ROE: 15.731637733928268%
Net margin: 15.539696699375558%
Asset turnover: 0.5611932011473263
Equity multiplier (leverage): 1.8039271625665505
EBIT margin: 20.67350579839429%
Interest burden factor: 0.9385113268608414
Tax burden factor: 0.8009195402298851
ROE archetype: Balanced Compounder
DuPont ROE decomposition for CG1.AX (annual period ending 2021-06-30)
ROE: -63.648412719630755%
Net margin: -43.722096459723026%
Asset turnover: 0.6421747744361099
Equity multiplier (leverage): 2.266905194753114
EBIT margin: -48.46494095794322%
ROE archetype: Low Return
DuPont ROE decomposition for CG1.AX (annual period ending 2022-06-30)
ROE: -44.01678313634942%
Net margin: -24.32745851923343%
Asset turnover: 0.8504319705185165
Equity multiplier (leverage): 2.127560804830148
EBIT margin: -21.203884007942797%
ROE archetype: Low Return
DuPont ROE decomposition for CG1.AX (annual period ending 2023-06-30)
ROE: -42.95518238759468%
Net margin: -38.770531868601225%
Asset turnover: 0.5403846467670244
Equity multiplier (leverage): 2.05026881970038
EBIT margin: -34.964673665844835%
ROE archetype: Low Return
DuPont ROE decomposition for CG1.AX (annual period ending 2024-06-30)
ROE: -60.352219100994084%
Net margin: -53.677382132890905%
Asset turnover: 0.45536219781780923
Equity multiplier (leverage): 2.46913560394578
EBIT margin: -38.62102170117619%
ROE archetype: Low Return
DuPont ROE decomposition for CGBD (quarterly period ending 2025-03-31)
ROE: 1.1591989039821378%
Net margin: 84.27175151406128%
Asset turnover: 0.006581793095609454
Equity multiplier (leverage): 2.089929882240766
Tax burden factor: 0.9541072640868975
ROE archetype: Low Return
DuPont ROE decomposition for CGBD (quarterly period ending 2025-06-30)
ROE: 1.2139834631056485%
Net margin: 84.39573117969425%
Asset turnover: 0.006786747930159333
Equity multiplier (leverage): 2.119486094163793
Tax burden factor: 0.9746835443037974
ROE archetype: Low Return
DuPont ROE decomposition for CGBD (quarterly period ending 2025-09-30)
ROE: 1.9998678077590153%
Net margin: 90.14557248453764%
Asset turnover: 0.010332379106663812
Equity multiplier (leverage): 2.1471211792886553
Tax burden factor: 0.9795107158955866
ROE archetype: Low Return
DuPont ROE decomposition for CGBD (quarterly period ending 2025-12-31)
ROE: 1.4733125761656414%
Net margin: 84.97482770418885%
Asset turnover: 0.007650951469991266
Equity multiplier (leverage): 2.2661526245048704
Tax burden factor: 0.9802650126867776
ROE archetype: Low Return
DuPont ROE decomposition for CGBD (quarterly period ending 2026-03-31)
ROE: -0.36936026154699597%
Asset turnover: -0.00046636174262965194
Equity multiplier (leverage): 2.3414620904407233
ROE archetype: Low Return
DuPont ROE decomposition for CGEM (quarterly period ending 2025-03-31)
ROE: -8.788976494955957%
Asset turnover: 0
Equity multiplier (leverage): 1.0504531212908113
ROE archetype: Low Return
DuPont ROE decomposition for CGEM (quarterly period ending 2025-06-30)
ROE: -13.420690910310014%
Asset turnover: 0
Equity multiplier (leverage): 1.0536645641460365
ROE archetype: Low Return
DuPont ROE decomposition for CGEM (quarterly period ending 2025-09-30)
ROE: -10.727969348659004%
Asset turnover: 0
Equity multiplier (leverage): 1.0645882683370165
ROE archetype: Low Return
DuPont ROE decomposition for CGEM (quarterly period ending 2025-12-31)
ROE: -11.792363437232225%
Asset turnover: 0
Equity multiplier (leverage): 1.0841775190995455
ROE archetype: Low Return
DuPont ROE decomposition for CGEM (quarterly period ending 2026-03-31)
ROE: -12.817362711671928%
Asset turnover: 0
Equity multiplier (leverage): 1.0986653796221975
ROE archetype: Low Return
DuPont ROE decomposition for CHAR.L (annual period ending 2021-12-31)
ROE: -17.864476386036966%
Asset turnover: 0
Equity multiplier (leverage): 1.4052361396303903
ROE archetype: Low Return
DuPont ROE decomposition for CHAR.L (annual period ending 2022-12-31)
ROE: -28.4128609535368%
Asset turnover: 0
Equity multiplier (leverage): 1.2316364327807203
ROE archetype: Low Return
DuPont ROE decomposition for CHAR.L (annual period ending 2023-12-31)
ROE: -24.522709197213718%
Net margin: -19463.75%
Asset turnover: 0.0011510750460191654
Equity multiplier (leverage): 1.0945567696487517
EBIT margin: -19421.25%
ROE archetype: Low Return
DuPont ROE decomposition for CHAR.L (annual period ending 2024-12-31)
ROE: -34.91193826802119%
Asset turnover: 0
Equity multiplier (leverage): 1.0877447443601178
ROE archetype: Low Return
DuPont ROE decomposition for CHAR.L (annual period ending 2025-12-31)
ROE: 0.5783671814344136%
Asset turnover: 0
Equity multiplier (leverage): 1.0957805389921116
Tax burden factor: 0.7263157894736841
ROE archetype: Low Return
DuPont ROE decomposition for CHCI (annual period ending 2022-12-31)
ROE: 32.55354543564151%
Net margin: 23.89285986823697%
Asset turnover: 0.9255997928095496
Equity multiplier (leverage): 1.4719969501628891
EBIT margin: 20.227405692773385%
Interest burden factor: 0.9875503018108652
Tax burden factor: 1.196103399974532
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CHCI (annual period ending 2023-12-31)
ROE: 23.562887846223703%
Net margin: 17.405693074841796%
Asset turnover: 0.9678613167121153
Equity multiplier (leverage): 1.3986983502345998
EBIT margin: 20.491491692940677%
Interest burden factor: 0.8895678742907027
Tax burden factor: 0.9548577036310107
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CHCI (annual period ending 2024-12-31)
ROE: 32.50544175922309%
Net margin: 28.38538620501423%
Asset turnover: 0.8935769907496124
Equity multiplier (leverage): 1.2815315063905788
EBIT margin: 20.054977190314656%
Interest burden factor: 1.042578011081948
Tax burden factor: 1.3575757575757577
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CHCI (annual period ending 2025-12-31)
ROE: 27.875914497077698%
Net margin: 27.124926424969374%
Asset turnover: 0.8391032443652431
Equity multiplier (leverage): 1.2247435321044673
EBIT margin: 18.97838087208285%
Interest burden factor: 1.079379715004191
Tax burden factor: 1.324143822318863
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CHEMCON.NS (annual period ending 2023-03-31)
ROE: 12.049634521320336%
Net margin: 18.294720069049077%
Asset turnover: 0.5443775155559668
Equity multiplier (leverage): 1.2098956815333948
EBIT margin: 20.70456620246651%
Interest burden factor: 1.1889067395229072
Tax burden factor: 0.7432105125459532
ROE archetype: Standard Business
DuPont ROE decomposition for CHEMCON.NS (annual period ending 2024-03-31)
ROE: 4.079477325011408%
Net margin: 7.229976772762579%
Asset turnover: 0.47948301588818587
Equity multiplier (leverage): 1.1767776004042916
EBIT margin: 6.242009280347406%
Interest burden factor: 1.5846182627954835
Tax burden factor: 0.730950277253062
ROE archetype: Low Return
DuPont ROE decomposition for CHEMCON.NS (annual period ending 2025-03-31)
ROE: 4.943063193613376%
Net margin: 11.789724100755153%
Asset turnover: 0.37260949312539027
Equity multiplier (leverage): 1.1252230117023372
EBIT margin: 10.774400222177437%
Interest burden factor: 1.4833059611658306
Tax burden factor: 0.7377000217218159
ROE archetype: Low Return
DuPont ROE decomposition for CHEMCON.NS (annual period ending 2026-03-31)
ROE: 4.5581821848682695%
Net margin: 9.833447857290787%
Asset turnover: 0.4070815543808764
Equity multiplier (leverage): 1.1386871928030926
EBIT margin: 7.7585571064789445%
Interest burden factor: 1.7164655269645361
Tax burden factor: 0.7383967432968175
ROE archetype: Low Return
DuPont ROE decomposition for CHER.V (annual period ending 2023-04-30)
Net margin: -11.39148035018281%
Asset turnover: 2.891666970551003
EBIT margin: 6.961049863848823%
Interest burden factor: -1.6364600991213654
ROE archetype: Standard Business
DuPont ROE decomposition for CHER.V (annual period ending 2024-04-30)
Net margin: -37.628303290088404%
Asset turnover: 2.9177498033850484
EBIT margin: -20.60540576643844%
ROE archetype: Standard Business
DuPont ROE decomposition for CHER.V (annual period ending 2025-04-30)
Net margin: -80.90015396012579%
Asset turnover: 0.6583801972691479
EBIT margin: -61.03311894422975%
ROE archetype: Standard Business
DuPont ROE decomposition for CHEV.TO (annual period ending 2022-12-31)
ROE: 22.22139014740205%
Net margin: 15.10625029166331%
Asset turnover: 0.9146634382190765
Equity multiplier (leverage): 1.6082487737297337
EBIT margin: 16.948289686361186%
Interest burden factor: 1.243404255319149
Tax burden factor: 0.7168337560897048
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CHEV.TO (annual period ending 2023-12-31)
ROE: 13.48902846990783%
Net margin: 10.873329846175722%
Asset turnover: 0.7695501435785351
Equity multiplier (leverage): 1.6120599371551882
EBIT margin: 13.32009567677096%
Interest burden factor: 1.1279118532921577
Tax burden factor: 0.7237358031368306
ROE archetype: Standard Business
DuPont ROE decomposition for CHEV.TO (annual period ending 2024-12-31)
ROE: 10.803454561178768%
Net margin: 9.176688347275793%
Asset turnover: 0.7158541204280009
Equity multiplier (leverage): 1.6445691448634667
EBIT margin: 9.780574312097366%
Interest burden factor: 1.4540360522281544
Tax burden factor: 0.6452773940231223
ROE archetype: Standard Business
DuPont ROE decomposition for CHEV.TO (annual period ending 2025-12-31)
ROE: 7.367806615251252%
Net margin: 6.769432636418843%
Asset turnover: 0.6469375767147197
Equity multiplier (leverage): 1.6823779590640635
EBIT margin: 9.04073045892253%
Interest burden factor: 1.184059014033825
Tax burden factor: 0.6323760320113457
ROE archetype: Standard Business
DuPont ROE decomposition for CHL.L (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.4236087127876127
ROE archetype: Standard Business
DuPont ROE decomposition for CHL.L (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.2323457798506368
ROE archetype: Standard Business
DuPont ROE decomposition for CHL.L (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.1295900220390194
ROE archetype: Standard Business
DuPont ROE decomposition for CHPT (quarterly period ending 2025-01-31)
ROE: -42.77483978439089%
Net margin: -57.71280511144481%
Asset turnover: 0.11344003117432572
Equity multiplier (leverage): 6.533559805340762
EBIT margin: -53.930257437014795%
ROE archetype: Low Return
DuPont ROE decomposition for CHPT (quarterly period ending 2025-04-30)
ROE: -44.61549877176744%
Net margin: -58.501638672675135%
Asset turnover: 0.10874365109815606
Equity multiplier (leverage): 7.01316102929403
EBIT margin: -55.141335518230235%
ROE archetype: Low Return
DuPont ROE decomposition for CHPT (quarterly period ending 2025-07-31)
ROE: -69.91859611310967%
Net margin: -67.12546911451466%
Asset turnover: 0.11153585517421609
Equity multiplier (leverage): 9.338795476035774
EBIT margin: -59.82046860736383%
ROE archetype: Low Return
DuPont ROE decomposition for CHPT (quarterly period ending 2025-10-31)
ROE: -96.20524665896717%
Net margin: -49.66122224955997%
Asset turnover: 0.12299924285058317
Equity multiplier (leverage): 15.749940420539332
EBIT margin: -41.954501580331964%
ROE archetype: Low Return
DuPont ROE decomposition for CHPT (quarterly period ending 2026-01-31)
ROE: -148.84889916557756%
Net margin: -40.631174533479694%
Asset turnover: 0.13329447813114606
Equity multiplier (leverage): 27.483629905164037
EBIT margin: -48.468715697036224%
ROE archetype: Low Return
DuPont ROE decomposition for CHPT (quarterly period ending 2026-04-30)
ROE: -708.43650077888%
Net margin: -42.43215902729353%
Asset turnover: 0.13457138816600736
Equity multiplier (leverage): 124.0660818233992
EBIT margin: -46.31159213899174%
ROE archetype: Low Return
DuPont ROE decomposition for CHRT.L (quarterly period ending 2024-10-31)
Equity multiplier (leverage): 2.500274273176083
ROE archetype: Standard Business
DuPont ROE decomposition for CHRT.L (quarterly period ending 2025-04-30)
Equity multiplier (leverage): 2.4865044597726778
ROE archetype: Standard Business
DuPont ROE decomposition for CHRT.L (quarterly period ending 2025-10-31)
Equity multiplier (leverage): 2.4785832257105884
ROE archetype: Standard Business
DuPont ROE decomposition for CHS.V (quarterly period ending 2024-12-31)
Net margin: -76.80038089446859%
Asset turnover: 1.4515214063412234
EBIT margin: -43.02661193947917%
ROE archetype: Standard Business
DuPont ROE decomposition for CHS.V (quarterly period ending 2025-03-31)
Net margin: -14.837791919060503%
Asset turnover: 1.3101834879058665
EBIT margin: 1.1812605469691695%
Interest burden factor: -12.560981535471331
ROE archetype: Standard Business
DuPont ROE decomposition for CHS.V (quarterly period ending 2025-06-30)
Net margin: -6.65661739643891%
Asset turnover: 1.0894267443970673
EBIT margin: 1.2231946117989314%
Interest burden factor: -5.44215070643642
ROE archetype: Standard Business
DuPont ROE decomposition for CHS.V (quarterly period ending 2025-09-30)
Net margin: -15.642952070173125%
Asset turnover: 1.2101809968173598
EBIT margin: -10.796845739100517%
ROE archetype: Standard Business
DuPont ROE decomposition for CHS.V (quarterly period ending 2025-12-31)
Net margin: -191.34980238021083%
Asset turnover: 1.0062120505725691
EBIT margin: -119.98175142457328%
ROE archetype: Standard Business
DuPont ROE decomposition for CHS.V (quarterly period ending 2026-03-31)
Net margin: -41.86286658405617%
Asset turnover: 0.7538497319616047
EBIT margin: -44.84116101597362%
ROE archetype: Standard Business
DuPont ROE decomposition for CI (quarterly period ending 2025-03-31)
ROE: 3.486415598554956%
Net margin: 2.158923755822505%
Asset turnover: 0.43319305977777484
Equity multiplier (leverage): 3.7278665808878113
EBIT margin: 2.655368962981123%
Interest burden factor: 0.9509521061742643
Tax burden factor: 0.8549757281553398
ROE archetype: Low Return
DuPont ROE decomposition for CI (quarterly period ending 2025-06-30)
ROE: 4.037405373311563%
Net margin: 2.437931343551134%
Asset turnover: 0.4428713667141898
Equity multiplier (leverage): 3.7394117064964623
EBIT margin: 3.092229093842431%
Interest burden factor: 0.976328502415459
Tax burden factor: 0.8075210291934686
ROE archetype: Low Return
DuPont ROE decomposition for CI (quarterly period ending 2025-09-30)
ROE: 4.786279171316287%
Net margin: 2.8382363518665037%
Asset turnover: 0.44910682559679554
Equity multiplier (leverage): 3.7549124254039103
EBIT margin: 3.3733726533841617%
Interest burden factor: 0.9786780383795309
Tax burden factor: 0.8596949891067538
ROE archetype: Low Return
DuPont ROE decomposition for CI (quarterly period ending 2025-12-31)
ROE: 3.0373831775700935%
Net margin: 1.7661819139644823%
Asset turnover: 0.4567721426807414
Equity multiplier (leverage): 3.7649961853900438
EBIT margin: 2.780974034075943%
Interest burden factor: 0.9057826520438684
Tax burden factor: 0.7011557512383049
ROE archetype: Low Return
DuPont ROE decomposition for CI (quarterly period ending 2026-03-31)
ROE: 4.414346031595427%
Net margin: 2.7250629649153635%
Asset turnover: 0.43891575750759193
Equity multiplier (leverage): 3.690699274159116
EBIT margin: 3.1570315703157035%
Interest burden factor: 1.0528756957328387
Tax burden factor: 0.8198237885462555
ROE archetype: Low Return
DuPont ROE decomposition for CIA (annual period ending 2022-12-31)
ROE: 20.35135769622036%
Net margin: 11.184651906899932%
Asset turnover: 0.14617687902770032
Equity multiplier (leverage): 12.447789341889036
Tax burden factor: 0.949957993936516
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CIA (annual period ending 2023-12-31)
ROE: 16.29573318129228%
Net margin: 10.153315605783613%
Asset turnover: 0.1476731568695966
Equity multiplier (leverage): 10.868371126870922
Tax burden factor: 0.9336364331015512
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for CIA (annual period ending 2024-12-31)
ROE: 7.7974503508643505%
Net margin: 6.086505769364207%
Asset turnover: 0.1460837927252357
Equity multiplier (leverage): 8.76965572416101
Tax burden factor: 0.9954606141522029
ROE archetype: Standard Business
DuPont ROE decomposition for CIA (annual period ending 2025-12-31)
ROE: 6.552746216374006%
Net margin: 5.708171632448673%
Asset turnover: 0.1486102814319995
Equity multiplier (leverage): 7.724626128351372
Tax burden factor: 0.8352032054951345
ROE archetype: Standard Business
DuPont ROE decomposition for CII (annual period ending 2022-12-31)
ROE: -13.956663437477307%
Asset turnover: -0.13700291164050082
Equity multiplier (leverage): 1.0139735099002634
ROE archetype: Low Return
DuPont ROE decomposition for CII (annual period ending 2023-12-31)
ROE: 18.459254530913142%
Net margin: 99.61346887145669%
Asset turnover: 0.1819114199746518
Equity multiplier (leverage): 1.0186761315717805
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CII (annual period ending 2024-12-31)
ROE: 14.05378502911109%
Net margin: 99.27406312891335%
Asset turnover: 0.1389709971948025
Equity multiplier (leverage): 1.0186695749713968
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CII (annual period ending 2025-12-31)
ROE: 22.758759000303506%
Net margin: 99.63549343149703%
Asset turnover: 0.21575256024608075
Equity multiplier (leverage): 1.0587137244767157
Tax burden factor: 1
ROE archetype: High-Margin Compounder
DuPont ROE decomposition for CINT (annual period ending 2022-12-31)
ROE: 7.462501994574756%
Net margin: 4.410935971044906%
Asset turnover: 0.7368908472667944
Equity multiplier (leverage): 2.2958871868517634
EBIT margin: 12.896334634111836%
Interest burden factor: 0.7098219183091381
Tax burden factor: 0.48185354042706635
ROE archetype: Standard Business
DuPont ROE decomposition for CINT (annual period ending 2023-12-31)
ROE: 10.105261910754272%
Net margin: 5.898515023168502%
Asset turnover: 0.8201903085511729
Equity multiplier (leverage): 2.0887682188404204
EBIT margin: 12.569611784947968%
Interest burden factor: 0.7422524430837146
Tax burden factor: 0.6322213961965515
ROE archetype: Standard Business
DuPont ROE decomposition for CINT (annual period ending 2024-12-31)
ROE: 9.05328029999045%
Net margin: 6.7190479336433055%
Asset turnover: 0.7071465699322858
Equity multiplier (leverage): 1.9054115276225336
EBIT margin: 13.137841402766986%
Interest burden factor: 0.7589561297034852
Tax burden factor: 0.6738559254266718
ROE archetype: Standard Business
DuPont ROE decomposition for CINT (annual period ending 2025-12-31)
ROE: 14.576596582831572%
Net margin: 8.295721433677116%
Asset turnover: 0.9626579616982994
Equity multiplier (leverage): 1.8252819843304586
EBIT margin: 12.655774532829572%
Interest burden factor: 0.9056625086736917
Tax burden factor: 0.7237674393742316
ROE archetype: Standard Business
DuPont ROE decomposition for CISS (quarterly period ending 2025-03-31)
ROE: 9.995478271461886%
Net margin: 91.30605222391272%
Asset turnover: 0.08369661995607451
Equity multiplier (leverage): 1.307964913588447
EBIT margin: 14.234111712782319%
Interest burden factor: 6.414594325680283
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CISS (quarterly period ending 2025-06-30)
ROE: -7.2118433974116325%
Net margin: -49.62541470928417%
Asset turnover: 0.11556857944735613
Equity multiplier (leverage): 1.257483697734404
EBIT margin: 9.850222694799394%
Interest burden factor: -5.037999266299312
ROE archetype: Low Return
DuPont ROE decomposition for CISS (quarterly period ending 2025-09-30)
ROE: 3.479373044795933%
Net margin: 55.72586805417941%
Asset turnover: 0.05316478514650251
Equity multiplier (leverage): 1.1744109427193095
EBIT margin: -73.56669735782117%
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for CISS (quarterly period ending 2025-12-31)
ROE: 5.989915296936851%
Net margin: 49.3984759147321%
Asset turnover: 0.11183943966640347
Equity multiplier (leverage): 1.0842068546526007
EBIT margin: 24.630171536580523%
Interest burden factor: 2.0056082776916884
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for CISS (quarterly period ending 2026-03-31)
ROE: 3.2073585145642167%
Net margin: 27.646016448428067%
Asset turnover: 0.1110942638633212
Equity multiplier (leverage): 1.0442952675272712
EBIT margin: 45.48226282118453%
Interest burden factor: 0.6078417108911132
Tax burden factor: 1
ROE archetype: Low Return